COVID-19 a complex multi-organ disease requires comprehensive diagnostic solutions
HUMAN supports laboratories with comprehensive solutions for the diagnosis of a wide range of aspects of COVID-19. For triage of SARS-CoV-2 patients, parameters of hematology and clinical chemistry are recommended. Coagulation parameters provide information on the prognosis of the patients.
COVID-19 related diagnostic solutions
Genetic characteristics influence susceptibility to COVID-19 Blood group A a risk factor for COVID-19?
The rapid global spread of the noval SARS-CoV-2 virus is straining existing health resources, so identifying infected persons and prioritising people at high risk has become a critical challenge.
Publication about COVID-19 Kidney disease
An early warning for severity and complications
Several publications indicate that the novel coronavirus SARS-CoV-2 does not only affect the lungs but also impacts numerous other organs, like kidneys which have been observed to be the second most frequently affected organs.
Main laboratory abnormalities associated with COVID-19
Although RT-PCR is the recommended testing for diagnosis of a SARS-CoV-2 infection, there are numerous other diagnostic parameters that show abnormal laboratory results in COVID-19 patients.
Enhancing the expeditious triage of COVID-19 patients through the utilization of hematology and CRP
In many countries, health organizations fear that they will find themselves in a situation where too many patients seek help in clinics, similar to the COVID 19 outbreak in Wuhan/China.
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
According to recent observations, coagulopathy often occurs in severe cases of COVID-19 patients. Coagulopathy is a condition in which the ability of the blood to clot is impaired - a term that includes the thrombotic state in sepsis.
Webinars on demand
Autoantibodies in COVID and Long-COVID - more cases of thrombosis and autoimmune disease on the horizon?
Since 2020 the corona virus keeps changing the world. But not only the mutations of the virus and the disease itself, but also lasting complications, such as long COVID are a topic of concern. As recent studies show, raised levels of autoantibodies, that are associated to COVID-19 can lead to the development of various autoimmune reactions and diseases. In this webinar we will have a spotlight on autoantibodies that specifically trigger platelet activation.
Click here to watch the webinar
Supporting faster triage of COVID-19 patients through the use of hematology and the role of blood groups in SARS-CoV-2 infection
Get an overview on strategies of fast decision makings on COVID-19 patients and learn about blood groups as a risk factor for a severe progress of the disease. Use the chance to exchange ideas with our product specialists in hematology and blood grouping.
Thromboinflammation in COVID-19: the importance of D-dimer and coagulation assays
Thrombotic and inflammatory events both contribute to acute organ damage in thromboinflammation, which is a typical characteristic of a severe course of COVID-19.
Click here to watch the webinar
Supporting faster triage of COVID-19 patients by the use of hematology and CRP
Learn more about the clinical and technical background also regarding COVID-19 for this very interesting win-win relationship and discuss with our specialists for hematology and COVID-19.
Click here to watch the webinar
The importance of D-dimer and other Hemostasis parameters in COVID-19 patients
Learn more about the clinical background regarding the importance of D-dimer and other Hemostasis parameters
Publications
COVID-19 Publication List
This document contains a selection of relevant scientific publications related to COVID-19.The content has been compiled to the best of our knowledge and belief and makes no claim to completeness or correctness.
Interim Guidance on the Use of Rapid Antigen Tests for COVID-19 Response
This document provides guidance to Ministries of Health (MOHs), laboratorypersonnel and implementing partners in African Union Member States on theapplication of rapid antigen tests to COVID-19 testing.
